The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism

Objectives. Nocturnal bruxism can be managed by botulinum toxin (Botox®) in patients who have not responded to conservative treatment. The aim of this study was to evaluate the efficacy of botulinum toxin A (BTXA) in the treatment of nocturnal bruxism. Material and Methods. The retrospective study c...

Full description

Saved in:
Bibliographic Details
Published in:Pain research & management 2017-01, Vol.2017 (2017), p.1-5
Main Authors: Acar, Ahmet H., Asutay, Hilal, Atalay, Yusuf, Asutay, Fatih
Format: Article
Language:English
Subjects:
Adult
Botulinum toxin
Botulinum Toxins - therapeutic use
Bruxism
Dosage and administration
Drug therapy
Female
Humans
Middle Aged
Neuromuscular Agents - therapeutic use
Pain - drug therapy
Pain Measurement - methods
Patient outcomes
Retrospective Studies
Sleep Bruxism - drug therapy
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives. Nocturnal bruxism can be managed by botulinum toxin (Botox®) in patients who have not responded to conservative treatment. The aim of this study was to evaluate the efficacy of botulinum toxin A (BTXA) in the treatment of nocturnal bruxism. Material and Methods. The retrospective study comprised 25 female patients, aged 23–55 years (mean 35.84±8.41 years). All patients received a single injection of BTXA in the right and left masseters. Evaluation was made by Visual Analogue Scale (VAS) values, complaint duration, onset of effect, and duration of effectiveness. Results. BTXA produced significant improvements in pain scores. Only 2 adverse events (8%) were recorded. Conclusion. BTX-A is effective in the treatment of nocturnal bruxism.
ISSN:1203-6765
1918-1523
DOI:10.1155/2017/6264146